A sugar-burning enzyme that helps brain tumors grow
Original title: Hexokinases and Glial Tumor Metabolism: A Bridge between Bioenergetics and Translational Oncology.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of where the science is heading, not a new test in people.
The short version
Brain tumor cells burn a lot of sugar, and scientists want to block the enzyme that lets them do it.
What was studied. This is a review paper. The authors pulled together past research on an enzyme called hexokinase 2 in glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary and other fast-growing brain tumors.
What they found. Tumors with high levels of this enzyme tend to grow faster and spread more. They also resist chemotherapy and radiation more often, and outcomes are worse. Many signals inside the cell can turn the enzyme up. The enzyme may also help the tumor hold back the immune system.
What this means, and what it doesn't
What it could mean: If a drug could block this enzyme, it might slow these tumors or help current treatments work better. That idea is still being studied. Nothing here changes your care today.
What it doesn't mean: This is a review of earlier lab and tumor research, not a new result. No treatment was tested in people here. There is no proof yet that blocking this enzyme helps anyone live longer or feel better. It is not a cure, and it is still a long way from the clinic.
Source: PubMed, October 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.